サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1292486

子宮頸がん診断の世界市場規模、シェア、産業動向分析レポートタイプ別（子宮頚部細胞診、コルポスコピー検査、HPV検査、生検・ECC）、年齢層別（20～40歳、40歳以上）、地域別展望・予測、2023～2029年

Global Cervical Cancer Diagnostic Market Size, Share & Industry Trends Analysis Report By Type (Pap Smear Tests, Colposcopy Tests, HPV Test, Biopsy & ECC), By Age Group (20 to 40 years, and Above 40 years), By Regional Outlook and Forecast, 2023 - 2029

出版日
発行
KBV Research
ページ情報
英文 182 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
子宮頸がん診断の世界市場規模、シェア、産業動向分析レポートタイプ別（子宮頚部細胞診、コルポスコピー検査、HPV検査、生検・ECC）、年齢層別（20～40歳、40歳以上）、地域別展望・予測、2023～2029年
出版日: 2023年05月31日
発行: KBV Research
ページ情報: 英文 182 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

子宮頸がん診断の市場規模は、2029年までに102億米ドルに達すると予測され、予測期間中にCAGR4.4%の市場成長率で上昇すると予想されています。

KBV Cardinalマトリックスで提示された分析に基づき、F. Hoffmann-La Roche Ltd.が本市場の先行者となっています。2023年5月、ロシュ・ダイアグノスティックスは、インドにおける子宮頸がんの状況を改善するため、Cancer Awareness Prevention and Early Detection Trust（CAPED）と契約を締結しました。このパートナーシップは、世界中のがん医療を強化するロシュの取り組みの一環です。Abbott Laboratories、Thermo Fisher Scientific, Inc.、Becton, Dickinson and Companyなどの企業が、この市場の主要なイノベーターとして挙げられます。

市場の成長要因

がんの治療と診断のためのイニシアチブの増加

各国の可処分所得の増加に伴い、ヘルスケアへの支出は世界的に増加しています。また、政府機関や医療機関では、人口の要求に応えるため、ヘルスケアへの支出を加速しています。子宮頸がんは近年ますます増加しており、医療費の増加により、ヘルスケア機関は同疾患の診断・治療設備を強化することができます。また、市場参入企業の戦略的な取り組みにより、市場の構造的な健全性が確保され、将来の成長機会がもたらされると考えられます。

子宮頸がん患者の増加

子宮頸がんは、早期に発見し、効果的に管理すれば、一度診断されれば最も治療効果の高い疾患の一つです。末期のがんも、正しい治療と緩和ケアによってコントロールすることが可能です。子宮頸がんは、予防、検診、治療において十分な対策がとられていれば、一世代で撲滅することが可能です。子宮頸がんの診断には、異常な細胞やヒトパピローマウイルス（HPV）の株を評価するいくつかの高度な臨床検査、機器、手順が使用されています。その結果、子宮頸がんの発生率の増加や早期診断による治療の可能性が、需要を増加させるでしょう。

市場抑制要因

有能な医療従事者の不足

2035年には、医療従事者が1,290万人不足すると予想され、現在の720万人から増加します。WHOの調査によると、医療従事者の不足は、早急に対策を講じなければ、世界中の何十億もの人々の健康に壊滅的な影響を与える可能性があります。このような状況の一因として、労働者の高齢化が挙げられ、退職やより高給な雇用への転職があっても、同等の人材がいないことが挙げられます。さらに、この分野では新入社員が不足しており、十分なトレーニングが行われていません。子宮頸がんなどの疾患の特定や治療は、世界のヘルスケア専門家の不足によって大きな影響を受けるため、市場の成長を阻害することになるでしょう。

タイプ別展望

市場は、タイプ別に、乳頭塗抹検査、HPV検査、生検・ECC、コルポスコピー検査、その他に分類されます。子宮頚部細胞診セグメントは、2022年に最大収益シェアを獲得し、市場を独占しました。これは、子宮頸がんを診断するためにパップスメア検査を利用する人が増えているためです。パップテストは、後にがんに進行する可能性のある異常な子宮頸部細胞の特定を支援します。この検査は非常に効率的であるため、シェアの大部分を占めています。また、早期診断がますます一般的になっていることから、この分野は成長しています。

年齢層別の展望

年齢層別では、20～40代と40代以上に分けられます。40歳以上のセグメントは、2022年の市場においてかなりの収益シェアを獲得しました。これは、子宮頸がん診断に対する政府の支援強化に起因しています。多くの高齢女性は、子宮頸がんの発症リスクが加齢とともに持続することを知らず、診断の需要と重要性を高めています。また、子宮頸がん患者の約5分の1が65歳以上の女性で診断されており、このセグメントの拡大を後押ししています。

地域別展望

地域別では、北米、欧州、アジア太平洋、LAMEAで分析されています。北米地域は、2022年の市場において最大の収益シェアを示しました。これは、病院で子宮頸がん診断サービスを利用する患者数の増加、市場参入企業の増加、同地域での製品供給力の上昇に起因しています。また、同地域では女性の疾病予防意識が高いことに加え、子宮頸がん予防のための数々の取り組みが導入され、特に低所得層の女性に対する子宮頸がんスクリーニング検査の保険適用が拡大したことが、大きな市場シェアの要因となっており、同地域の市場成長の一助となっています。

目次

第1章 市場範囲と調査手法

  • 市場の定義
  • 目的
  • 市場範囲
  • セグメンテーション
  • 調査手法

第2章 市場概要

  • イントロダクション
    • 概要
      • 市場構成とシナリオ
  • 市場に影響を与える主な要因
    • 市場促進要因
    • 市場抑制要因

第3章 競合分析- 世界

  • KBVカーディナルマトリックス
    • パートナーシップ、コラボレーション、および契約
    • 製品の発売と製品の拡大
    • 買収と合併
    • 承認とトライアル
    • 地理的および事業の拡大
  • 主要成功戦略
    • 主な戦略

第4章 世界の子宮頸がん診断市場：タイプ別

  • 世界の子宮頚部細胞診市場：地域別
  • 世界のコルポスコピー検査市場：地域別
  • 世界のHPV検査市場：地域別
  • 世界の生検およびECC市場：地域別
  • 世界のその他の市場：地域別

第5章 世界の子宮頸がん診断市場：年齢層別

  • 20年から40年の世界市場：地域別
  • 40歳以上の世界市場：地域別

第6章 世界の子宮頸がん診断市場：地域別

  • 北米
    • 北米の市場：国別
      • 米国
      • カナダ
      • メキシコ
      • その他北米地域
  • 欧州
    • 欧州の市場：国別
      • ドイツ
      • 英国
      • フランス
      • ロシア
      • スペイン
      • イタリア
      • その他欧州地域
  • アジア太平洋
    • アジア太平洋の市場：国別
      • 中国
      • 日本
      • インド
      • 韓国
      • シンガポール
      • マレーシア
      • その他アジア太平洋地域
  • ラテンアメリカ・中東・アフリカ
    • ラテンアメリカ・中東・アフリカの市場：国別
      • ブラジル
      • アルゼンチン
      • アラブ首長国連邦
      • サウジアラビア
      • 南アフリカ
      • ナイジェリア
      • その他ラテンアメリカ・中東・アフリカ地域

第7章 企業プロファイル

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Carl Zeiss AG
  • CooperSurgical, Inc（The Cooper Companies, Inc.）
  • DYSIS Medical, Inc
  • F Hoffmann-La Roche Ltd.
  • Hologic, Inc
  • Qiagen NV
  • Siemens Healthineers AG（Siemens AG）
  • Thermo Fisher Scientific, Inc
図表

LIST OF TABLES

  • TABLE 1 Global Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 2 Global Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Cervical Cancer Diagnostic Market
  • TABLE 4 Product Launches And Product Expansions- Cervical Cancer Diagnostic Market
  • TABLE 5 Acquisition and Mergers- Cervical Cancer Diagnostic Market
  • TABLE 6 Approvals and trials- Cervical Cancer Diagnostic Market
  • TABLE 7 Geographical and Business Expansions- Cervical Cancer Diagnostic Market
  • TABLE 8 Global Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 9 Global Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 10 Global Pap Smear Tests Market by Region, 2019 - 2022, USD Million
  • TABLE 11 Global Pap Smear Tests Market by Region, 2023 - 2029, USD Million
  • TABLE 12 Global Colposcopy Tests Market by Region, 2019 - 2022, USD Million
  • TABLE 13 Global Colposcopy Tests Market by Region, 2023 - 2029, USD Million
  • TABLE 14 Global HPV Test Market by Region, 2019 - 2022, USD Million
  • TABLE 15 Global HPV Test Market by Region, 2023 - 2029, USD Million
  • TABLE 16 Global Biopsy & ECC Market by Region, 2019 - 2022, USD Million
  • TABLE 17 Global Biopsy & ECC Market by Region, 2023 - 2029, USD Million
  • TABLE 18 Global Others Market by Region, 2019 - 2022, USD Million
  • TABLE 19 Global Others Market by Region, 2023 - 2029, USD Million
  • TABLE 20 Global Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 21 Global Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 22 Global 20 to 40 years Market by Region, 2019 - 2022, USD Million
  • TABLE 23 Global 20 to 40 years Market by Region, 2023 - 2029, USD Million
  • TABLE 24 Global Above 40 years Market by Region, 2019 - 2022, USD Million
  • TABLE 25 Global Above 40 years Market by Region, 2023 - 2029, USD Million
  • TABLE 26 Global Cervical Cancer Diagnostic Market by Region, 2019 - 2022, USD Million
  • TABLE 27 Global Cervical Cancer Diagnostic Market by Region, 2023 - 2029, USD Million
  • TABLE 28 North America Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 29 North America Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 30 North America Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 31 North America Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 32 North America Pap Smear Tests Market by Country, 2019 - 2022, USD Million
  • TABLE 33 North America Pap Smear Tests Market by Country, 2023 - 2029, USD Million
  • TABLE 34 North America Colposcopy Tests Market by Country, 2019 - 2022, USD Million
  • TABLE 35 North America Colposcopy Tests Market by Country, 2023 - 2029, USD Million
  • TABLE 36 North America HPV Test Market by Country, 2019 - 2022, USD Million
  • TABLE 37 North America HPV Test Market by Country, 2023 - 2029, USD Million
  • TABLE 38 North America Biopsy & ECC Market by Country, 2019 - 2022, USD Million
  • TABLE 39 North America Biopsy & ECC Market by Country, 2023 - 2029, USD Million
  • TABLE 40 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 41 North America Others Market by Country, 2023 - 2029, USD Million
  • TABLE 42 North America Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 43 North America Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 44 North America 20 to 40 years Market by Country, 2019 - 2022, USD Million
  • TABLE 45 North America 20 to 40 years Market by Country, 2023 - 2029, USD Million
  • TABLE 46 North America Above 40 years Market by Country, 2019 - 2022, USD Million
  • TABLE 47 North America Above 40 years Market by Country, 2023 - 2029, USD Million
  • TABLE 48 North America Cervical Cancer Diagnostic Market by Country, 2019 - 2022, USD Million
  • TABLE 49 North America Cervical Cancer Diagnostic Market by Country, 2023 - 2029, USD Million
  • TABLE 50 US Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 51 US Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 52 US Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 53 US Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 54 US Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 55 US Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 56 Canada Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 57 Canada Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 58 Canada Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 59 Canada Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 60 Canada Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 61 Canada Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 62 Mexico Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 63 Mexico Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 64 Mexico Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 65 Mexico Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 66 Mexico Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 67 Mexico Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 68 Rest of North America Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 69 Rest of North America Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 70 Rest of North America Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 71 Rest of North America Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 72 Rest of North America Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 73 Rest of North America Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 74 Europe Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 75 Europe Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 76 Europe Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 77 Europe Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 78 Europe Pap Smear Tests Market by Country, 2019 - 2022, USD Million
  • TABLE 79 Europe Pap Smear Tests Market by Country, 2023 - 2029, USD Million
  • TABLE 80 Europe Colposcopy Tests Market by Country, 2019 - 2022, USD Million
  • TABLE 81 Europe Colposcopy Tests Market by Country, 2023 - 2029, USD Million
  • TABLE 82 Europe HPV Test Market by Country, 2019 - 2022, USD Million
  • TABLE 83 Europe HPV Test Market by Country, 2023 - 2029, USD Million
  • TABLE 84 Europe Biopsy & ECC Market by Country, 2019 - 2022, USD Million
  • TABLE 85 Europe Biopsy & ECC Market by Country, 2023 - 2029, USD Million
  • TABLE 86 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 87 Europe Others Market by Country, 2023 - 2029, USD Million
  • TABLE 88 Europe Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 89 Europe Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 90 Europe 20 to 40 years Market by Country, 2019 - 2022, USD Million
  • TABLE 91 Europe 20 to 40 years Market by Country, 2023 - 2029, USD Million
  • TABLE 92 Europe Above 40 years Market by Country, 2019 - 2022, USD Million
  • TABLE 93 Europe Above 40 years Market by Country, 2023 - 2029, USD Million
  • TABLE 94 Europe Cervical Cancer Diagnostic Market by Country, 2019 - 2022, USD Million
  • TABLE 95 Europe Cervical Cancer Diagnostic Market by Country, 2023 - 2029, USD Million
  • TABLE 96 Germany Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 97 Germany Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 98 Germany Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 99 Germany Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 100 Germany Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 101 Germany Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 102 UK Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 103 UK Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 104 UK Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 105 UK Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 106 UK Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 107 UK Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 108 France Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 109 France Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 110 France Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 111 France Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 112 France Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 113 France Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 114 Russia Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 115 Russia Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 116 Russia Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 117 Russia Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 118 Russia Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 119 Russia Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 120 Spain Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 121 Spain Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 122 Spain Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 123 Spain Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 124 Spain Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 125 Spain Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 126 Italy Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 127 Italy Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 128 Italy Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 129 Italy Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 130 Italy Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 131 Italy Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 132 Rest of Europe Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 133 Rest of Europe Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 134 Rest of Europe Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 135 Rest of Europe Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 136 Rest of Europe Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 137 Rest of Europe Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 138 Asia Pacific Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 139 Asia Pacific Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 140 Asia Pacific Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 141 Asia Pacific Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 142 Asia Pacific Pap Smear Tests Market by Country, 2019 - 2022, USD Million
  • TABLE 143 Asia Pacific Pap Smear Tests Market by Country, 2023 - 2029, USD Million
  • TABLE 144 Asia Pacific Colposcopy Tests Market by Country, 2019 - 2022, USD Million
  • TABLE 145 Asia Pacific Colposcopy Tests Market by Country, 2023 - 2029, USD Million
  • TABLE 146 Asia Pacific HPV Test Market by Country, 2019 - 2022, USD Million
  • TABLE 147 Asia Pacific HPV Test Market by Country, 2023 - 2029, USD Million
  • TABLE 148 Asia Pacific Biopsy & ECC Market by Country, 2019 - 2022, USD Million
  • TABLE 149 Asia Pacific Biopsy & ECC Market by Country, 2023 - 2029, USD Million
  • TABLE 150 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
  • TABLE 151 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
  • TABLE 152 Asia Pacific Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 153 Asia Pacific Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 154 Asia Pacific 20 to 40 years Market by Country, 2019 - 2022, USD Million
  • TABLE 155 Asia Pacific 20 to 40 years Market by Country, 2023 - 2029, USD Million
  • TABLE 156 Asia Pacific Above 40 years Market by Country, 2019 - 2022, USD Million
  • TABLE 157 Asia Pacific Above 40 years Market by Country, 2023 - 2029, USD Million
  • TABLE 158 Asia Pacific Cervical Cancer Diagnostic Market by Country, 2019 - 2022, USD Million
  • TABLE 159 Asia Pacific Cervical Cancer Diagnostic Market by Country, 2023 - 2029, USD Million
  • TABLE 160 China Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 161 China Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 162 China Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 163 China Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 164 China Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 165 China Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 166 Japan Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 167 Japan Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 168 Japan Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 169 Japan Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 170 Japan Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 171 Japan Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 172 India Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 173 India Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 174 India Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 175 India Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 176 India Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 177 India Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 178 South Korea Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 179 South Korea Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 180 South Korea Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 181 South Korea Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 182 South Korea Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 183 South Korea Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 184 Singapore Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 185 Singapore Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 186 Singapore Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 187 Singapore Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 188 Singapore Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 189 Singapore Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 190 Malaysia Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 191 Malaysia Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 192 Malaysia Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 193 Malaysia Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 194 Malaysia Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 195 Malaysia Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 196 Rest of Asia Pacific Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 197 Rest of Asia Pacific Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 198 Rest of Asia Pacific Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 199 Rest of Asia Pacific Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 200 Rest of Asia Pacific Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 201 Rest of Asia Pacific Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 202 LAMEA Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 203 LAMEA Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 204 LAMEA Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 205 LAMEA Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 206 LAMEA Pap Smear Tests Market by Country, 2019 - 2022, USD Million
  • TABLE 207 LAMEA Pap Smear Tests Market by Country, 2023 - 2029, USD Million
  • TABLE 208 LAMEA Colposcopy Tests Market by Country, 2019 - 2022, USD Million
  • TABLE 209 LAMEA Colposcopy Tests Market by Country, 2023 - 2029, USD Million
  • TABLE 210 LAMEA HPV Test Market by Country, 2019 - 2022, USD Million
  • TABLE 211 LAMEA HPV Test Market by Country, 2023 - 2029, USD Million
  • TABLE 212 LAMEA Biopsy & ECC Market by Country, 2019 - 2022, USD Million
  • TABLE 213 LAMEA Biopsy & ECC Market by Country, 2023 - 2029, USD Million
  • TABLE 214 LAMEA Others Market by Country, 2019 - 2022, USD Million
  • TABLE 215 LAMEA Others Market by Country, 2023 - 2029, USD Million
  • TABLE 216 LAMEA Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 217 LAMEA Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 218 LAMEA 20 to 40 years Market by Country, 2019 - 2022, USD Million
  • TABLE 219 LAMEA 20 to 40 years Market by Country, 2023 - 2029, USD Million
  • TABLE 220 LAMEA Above 40 years Market by Country, 2019 - 2022, USD Million
  • TABLE 221 LAMEA Above 40 years Market by Country, 2023 - 2029, USD Million
  • TABLE 222 LAMEA Cervical Cancer Diagnostic Market by Country, 2019 - 2022, USD Million
  • TABLE 223 LAMEA Cervical Cancer Diagnostic Market by Country, 2023 - 2029, USD Million
  • TABLE 224 Brazil Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 225 Brazil Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 226 Brazil Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 227 Brazil Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 228 Brazil Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 229 Brazil Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 230 Argentina Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 231 Argentina Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 232 Argentina Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 233 Argentina Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 234 Argentina Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 235 Argentina Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 236 UAE Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 237 UAE Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 238 UAE Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 239 UAE Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 240 UAE Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 241 UAE Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 242 Saudi Arabia Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 243 Saudi Arabia Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 244 Saudi Arabia Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 245 Saudi Arabia Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 246 Saudi Arabia Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 247 Saudi Arabia Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 248 South Africa Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 249 South Africa Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 250 South Africa Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 251 South Africa Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 252 South Africa Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 253 South Africa Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 254 Nigeria Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 255 Nigeria Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 256 Nigeria Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 257 Nigeria Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 258 Nigeria Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 259 Nigeria Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 260 Rest of LAMEA Cervical Cancer Diagnostic Market, 2019 - 2022, USD Million
  • TABLE 261 Rest of LAMEA Cervical Cancer Diagnostic Market, 2023 - 2029, USD Million
  • TABLE 262 Rest of LAMEA Cervical Cancer Diagnostic Market by Type, 2019 - 2022, USD Million
  • TABLE 263 Rest of LAMEA Cervical Cancer Diagnostic Market by Type, 2023 - 2029, USD Million
  • TABLE 264 Rest of LAMEA Cervical Cancer Diagnostic Market by Age Group, 2019 - 2022, USD Million
  • TABLE 265 Rest of LAMEA Cervical Cancer Diagnostic Market by Age Group, 2023 - 2029, USD Million
  • TABLE 266 Key Information - Abbott Laboratories
  • TABLE 267 Key information - Becton, Dickinson and Company
  • TABLE 268 key Information - Carl Zeiss AG
  • TABLE 269 Key Information - CooperSurgical, Inc.
  • TABLE 270 Key information - DYSIS Medical, Inc.
  • TABLE 271 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
  • TABLE 272 Key Information - Hologic, Inc.
  • TABLE 273 Key Information - Qiagen N.V.
  • TABLE 274 Key Information - Siemens Healthineers AG
  • TABLE 275 Key Information - Thermo Fisher Scientific, Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
  • FIG 4 Global Cervical Cancer Diagnostic Market share by Type, 2022
  • FIG 5 Global Cervical Cancer Diagnostic Market share by Type, 2029
  • FIG 6 Global Cervical Cancer Diagnostic Market by Type, 2019 - 2029, USD Million
  • FIG 7 Global Cervical Cancer Diagnostic Market share by Age Group, 2022
  • FIG 8 Global Cervical Cancer Diagnostic Market share by Age Group, 2029
  • FIG 9 Global Cervical Cancer Diagnostic Market by Age Group, 2019 - 2029, USD Million
  • FIG 10 Global Cervical Cancer Diagnostic Market share by Region, 2022
  • FIG 11 Global Cervical Cancer Diagnostic Market share by Region, 2029
  • FIG 12 Global Cervical Cancer Diagnostic Market by Region, 2019 - 2029, USD Million
  • FIG 13 Swot analysis: Abbott laboratories
  • FIG 14 Recent strategies and developments: Becton, Dickinson and Company
  • FIG 15 Swot analysis: Becton, Dickinson and company
  • FIG 16 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
  • FIG 17 Recent strategies and developments: Hologic, Inc.
  • FIG 18 Recent strategies and developments: Qiagen N.V.
  • FIG 19 Swot analysis: Siemens AG
  • FIG 20 Swot analysis: thermo fisher scientific, inc.
目次

The Global Cervical Cancer Diagnostic Market size is expected to reach $10.2 billion by 2029, rising at a market growth of 4.4% CAGR during the forecast period.

Asia Pacific is the promising region for cervical cancer diagnostic because rise in the prevalence of obesity among women, an increase in instances of hazardous sexual behavior, particularly among adolescents, and an increase in the number of diverse strategies and trends adopted by market participants. Hence, APAC generated $1,929.4 million revenue in the market in 2022. Numerous public-private partnerships, rising R&D efforts, and strategic initiatives by market participants are creating opportunities for the market in the region.

The major strategies followed by the market participants are Partnerships as the key developmental strategy to keep pace with the changing demands of end users. For instance, In July 2021, QIAGEN partnered with Sysmex Corporation for developing cancer companion diagnostics by utilizing Qiagen's expertise and Sysmex's Plasma-Safe-SeqS technology. The partnership provides the company with NGS capabilities and would allow the company to serve its partners in a better way. Additionally, In August 2022, Becton, Dickinson, and Company announced a partnership with LabCorp for developing and selling flow cytometry-based companion diagnostics (CDx). The partnership allows BD to serve its customers in a better way by providing solutions for cancer diagnostics.

Based on the Analysis presented in the KBV Cardinal matrix; F. Hoffmann-La Roche Ltd. is the forerunner in the Market. In May 2023, Roche Diagnostics signed an agreement with Cancer Awareness Prevention and Early Detection Trust (CAPED) for improving the situation of cervical cancer in India. The partnership is part of Roche's efforts to enhance cancer care around the world. Companies such as Abbott Laboratories, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company are some of the key innovators in Market.

Market Growth Factors

Increasing initiatives for the treatment and diagnosis of cancer

Healthcare expenditures have increased globally as disposable income has risen in various countries. In addition, government bodies and healthcare organizations are accelerating healthcare expenditures to meet population requirements. As cervical cancer has become increasingly prevalent in recent years, the increase in healthcare expenditures enables healthcare institutions to enhance their diagnostic and therapeutic facilities for the disease. In addition, key market participants' strategic initiatives will provide structural integrity and future growth opportunities for the market.

Rising cases of cervical cancer

If detected early and managed effectively, cervical cancer is one of the most successfully treatable forms once diagnosed. Late-stage cancers can also be controlled with the correct treatment and palliative care. Cervical cancer can be eliminated within a single generation if enough measures are taken in prevention, screening, and treatment. Several advanced laboratory tests, instruments, and procedures that evaluate abnormal cells and strains of the human papillomavirus (HPV) are used to diagnose cervical cancer. Consequently, the growing incidence of cervical cancer and its treatability following early diagnosis will increase the demand.

Market Restraining Factors

A lack of qualified medical personnel

By 2035, there will likely be a shortage of 12.9 million healthcare workers, an increase from the 7.2 million that exist today. According to recent WHO research, the lack of healthcare workers might have a catastrophic impact on the health of billions of people worldwide if prompt actions are not taken. One reason contributing to this situation is the aging of the workforce, which causes retirements or leaves for higher-paying employment without comparable replacements. Additionally, the sector lacks fresh hires and offers inadequate training. The identification and treatment of illnesses like cervical cancer would be significantly impacted by a global scarcity of healthcare experts, which would impede the market growth.

Type Outlook

Based on type, the market is segmented into pap smear tests, HPV test, biopsy & ECC, colposcopy tests and others. The pap smear tests segment dominated the market with maximum revenue share in 2022. This is because more people are using Pap smear tests to diagnose cervical cancer. The Pap test aids in identifying abnormal cervix cells that may later progress to cancer. Due to this test's great efficiency, it makes up the majority of the shares. Additionally, this segment is growing as early diagnosis is becoming increasingly popular.

Age Group Outlook

On the basis of age group, the market is divided into 20 to 40 years and above 40 years. The above 40 years segment procured a substantial revenue share in the market in 2022. This is owing to the increased government support for cervical cancer diagnosis. Many elderly women are unaware that the risk of developing cervical cancer persists with age, increasing the demand and importance of diagnosis. In addition, approximately one-fifth of cervical cancer cases are diagnosed in women aged 65 and older, propelling the segment's expansion.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed the largest revenue share in the market in 2022. This is due to the increasing number of patients utilizing cervical cancer diagnosis services in hospitals, an increase in the number of market participants, joined with the rising availability of products in the region. In addition, the large market share is attributable to the high level of disease prevention awareness among women in the region, as well as the numerous initiatives introduced to prevent cervical cancer, which has expanded insurance coverage for cervical screening tests, particularly for low-income women, which is aiding the market growth in the region.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Becton, Dickinson and Company, Carl Zeiss AG, CooperSurgical, Inc. (The Cooper Companies, Inc.), DYSIS Medical, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Qiagen N.V., Siemens Healthineers AG (Siemens AG) and Thermo Fisher Scientific, Inc.

Recent Strategies deployed in Cervical Cancer Diagnostic Market

Acquisition and Mergers:

Jul-2022: Becton, Dickinson, and Company acquired Parata Systems, a pharmacy automation solutions provider. The acquisition aids the company in its growth strategy and allows the company to expand into the high-growth pharmacy automation sector.

Feb-2022: Becton, Dickinson, and Company acquired Cytognos, a flow cytometry solutions provider. The acquisition provides Becton, Dickinson, and Company with Euroflow Consortium which further allows the company to expand their capabilities into Post treatment monitoring.

May-2021: Roche announced the acquisition of GenMark Diagnostics, a molecular diagnostics company. The acquisition expands Roche's molecular diagnostics portfolio and enhances its capabilities in syndromic testing.

Apr-2021: Siemens Healthineers AG acquired Varian Medical Systems, Inc., a radiation oncology treatments provider. This acquisition places Siemens Healthineers AG as a major player in the MedTech sector.

Partnerships, Collaborations, and Agreements:

May-2023: Roche Diagnostics signed an agreement with Cancer Awareness Prevention and Early Detection Trust (CAPED), a non-profit organization aiming at spreading Cancer Awareness. The partnership aims at improving the situation of cervical cancer in India. The partnership is part of Roche's efforts to enhance cancer care around the world.

Aug-2022: Becton, Dickinson, and Company announced a partnership with LabCorp, a life science company. The partnership aims at developing and selling flow cytometry-based companion diagnostics (CDx). The partnership allows BD to serve its customers in a better way by providing solutions for cancer diagnostics.

Jul-2021: QIAGEN partnered with Sysmex Corporation, a healthcare company based in Japan. The partnership aims at developing cancer companion diagnostics by utilizing Qiagen's expertise and Sysmex's Plasma-Safe-SeqS technology. The partnership provides the company with NGS capabilities and would allow the company to serve its partners in a better way.

Feb-2021: Hologic, Inc. partnered with Google Cloud, a range of cloud-based services offered by Google. The partnership aims at enhancing cancer screening and removal of cervical cancer around the world by integrating google cloud's machine learning (MI) technology with Holigic's Genius™ Digital Diagnostics System. The partnership enhances Hologic's position as a premier provider of cancer screening solutions.

Trials and approvals:

Feb-2023: Becton, Dickinson, and Company have received approval from U.S. Food and Drug Administration (FDA) for its BD Onclarity™ HPV Assay. The BD Onclarity™ HPV Assay is used to detect human papillomavirus (HPV).

May-2021: Hologic received premarket approval for its ThinPrep GenesisTM processor. ThinPrep GenesisTM processor is used for specimen transfer and cytology processing applications. The features of the product include barcode scanning, sample aliquoting, slide labelling, and vial uncapping/capping.

Product Launches and Product Expansions:

May-2023: Becton, Dickinson, and Company unveiled BD FACSDiscover S8 Cell Sorter. BD FACSDiscover S8 Cell Sorter is used for detailed profiling of cells. The BD FACSDiscover S8 Cell Sorter features BD CellView Image Technology and BD SpectralFX Technology. The BD CellView Image Technology is used for cell characteristics sorting by providing the researchers with high-quality images of cells. The With BD SpectralFX Technology is used for full range cell sorting using AI-based algorithms and optical architecture.

Apr-2023: QIAGEN unveiled QIAseq Targeted cfDNA Ultra Panels. The QIAseq Targeted cfDNA Ultra Panels were designed for use by researchers for converting cfDNA liquid biopsy samples into libraries for further use in next-generation sequencing (NGS).

Jun-2022: Roche unveiled cobas HPV. The cobas HPV is a human papillomavirus (HPV) self-sampling solution that is designed for use by female patients to collect their samples.

Jul-2021: DYSIS Medical Ltd. announced the launch of DYSIS View. The DYSIS View is used for finding out cervical lesions. The DYSIS view features cervical mapping technology, DYSIS SMARTtrack, and a camera used for high-quality images and exam videos.

Aug-2021: Becton, Dickinson, and Company unveiled BD COR System, a self-controlled diagnostic system used for automating molecular laboratory workflow. The system features scalability, modularity, and onboard capacity for reagents. Furthermore, the system features a PX instrument, used for preparing samples, and GX instrument used for performing analysis.

Apr-2021: Hologic, Inc. unveiled Genius Digital Diagnostics System. Genius Digital Diagnostics System is used for detecting cervical cancer. The Genius Digital Diagnostics System features ThinPrep Pap test image to provide a single view image of relevant cells and GeniusTM Cervical AI that is used in sorting cells to AI-generated gallery.

Geographical Expansions:

Mar-2022: Hologic opened an innovation centre in France. The new centre would serve as a research and development and training hub for the company. The new centre aids the company in providing new technologies to the European market.

Scope of the Study

Market Segments covered in the Report:

By Type

  • Pap Smear Tests
  • Colposcopy Tests
  • HPV Test
  • Biopsy & ECC
  • Others

By Age Group

  • 20 to 40 years
  • Above 40 years

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Carl Zeiss AG
  • CooperSurgical, Inc. (The Cooper Companies, Inc.)
  • DYSIS Medical, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Qiagen N.V.
  • Siemens Healthineers AG (Siemens AG)
  • Thermo Fisher Scientific, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Cervical Cancer Diagnostic Market, by Type
    • 1.4.2 Global Cervical Cancer Diagnostic Market, by Age Group
    • 1.4.3 Global Cervical Cancer Diagnostic Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition & scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
    • 3.1.1 Partnerships, Collaborations and Agreements
    • 3.1.2 Product Launches and Product Expansions
    • 3.1.3 Acquisition and Mergers
    • 3.1.4 Approvals and Trials
    • 3.1.5 Geographical and Business Expansions
  • 3.2 Top Winning Strategies
    • 3.2.1 Key Leading Strategies: Percentage Distribution (2019-2023)

Chapter 4. Global Cervical Cancer Diagnostic Market by Type

  • 4.1 Global Pap Smear Tests Market by Region
  • 4.2 Global Colposcopy Tests Market by Region
  • 4.3 Global HPV Test Market by Region
  • 4.4 Global Biopsy & ECC Market by Region
  • 4.5 Global Others Market by Region

Chapter 5. Global Cervical Cancer Diagnostic Market by Age Group

  • 5.1 Global 20 to 40 years Market by Region
  • 5.2 Global Above 40 years Market by Region

Chapter 6. Global Cervical Cancer Diagnostic Market by Region

  • 6.1 North America Cervical Cancer Diagnostic Market
    • 6.1.1 North America Cervical Cancer Diagnostic Market by Type
      • 6.1.1.1 North America Pap Smear Tests Market by Country
      • 6.1.1.2 North America Colposcopy Tests Market by Country
      • 6.1.1.3 North America HPV Test Market by Country
      • 6.1.1.4 North America Biopsy & ECC Market by Country
      • 6.1.1.5 North America Others Market by Country
    • 6.1.2 North America Cervical Cancer Diagnostic Market by Age Group
      • 6.1.2.1 North America 20 to 40 years Market by Country
      • 6.1.2.2 North America Above 40 years Market by Country
    • 6.1.3 North America Cervical Cancer Diagnostic Market by Country
      • 6.1.3.1 US Cervical Cancer Diagnostic Market
        • 6.1.3.1.1 US Cervical Cancer Diagnostic Market by Type
        • 6.1.3.1.2 US Cervical Cancer Diagnostic Market by Age Group
      • 6.1.3.2 Canada Cervical Cancer Diagnostic Market
        • 6.1.3.2.1 Canada Cervical Cancer Diagnostic Market by Type
        • 6.1.3.2.2 Canada Cervical Cancer Diagnostic Market by Age Group
      • 6.1.3.3 Mexico Cervical Cancer Diagnostic Market
        • 6.1.3.3.1 Mexico Cervical Cancer Diagnostic Market by Type
        • 6.1.3.3.2 Mexico Cervical Cancer Diagnostic Market by Age Group
      • 6.1.3.4 Rest of North America Cervical Cancer Diagnostic Market
        • 6.1.3.4.1 Rest of North America Cervical Cancer Diagnostic Market by Type
        • 6.1.3.4.2 Rest of North America Cervical Cancer Diagnostic Market by Age Group
  • 6.2 Europe Cervical Cancer Diagnostic Market
    • 6.2.1 Europe Cervical Cancer Diagnostic Market by Type
      • 6.2.1.1 Europe Pap Smear Tests Market by Country
      • 6.2.1.2 Europe Colposcopy Tests Market by Country
      • 6.2.1.3 Europe HPV Test Market by Country
      • 6.2.1.4 Europe Biopsy & ECC Market by Country
      • 6.2.1.5 Europe Others Market by Country
    • 6.2.2 Europe Cervical Cancer Diagnostic Market by Age Group
      • 6.2.2.1 Europe 20 to 40 years Market by Country
      • 6.2.2.2 Europe Above 40 years Market by Country
    • 6.2.3 Europe Cervical Cancer Diagnostic Market by Country
      • 6.2.3.1 Germany Cervical Cancer Diagnostic Market
        • 6.2.3.1.1 Germany Cervical Cancer Diagnostic Market by Type
        • 6.2.3.1.2 Germany Cervical Cancer Diagnostic Market by Age Group
      • 6.2.3.2 UK Cervical Cancer Diagnostic Market
        • 6.2.3.2.1 UK Cervical Cancer Diagnostic Market by Type
        • 6.2.3.2.2 UK Cervical Cancer Diagnostic Market by Age Group
      • 6.2.3.3 France Cervical Cancer Diagnostic Market
        • 6.2.3.3.1 France Cervical Cancer Diagnostic Market by Type
        • 6.2.3.3.2 France Cervical Cancer Diagnostic Market by Age Group
      • 6.2.3.4 Russia Cervical Cancer Diagnostic Market
        • 6.2.3.4.1 Russia Cervical Cancer Diagnostic Market by Type
        • 6.2.3.4.2 Russia Cervical Cancer Diagnostic Market by Age Group
      • 6.2.3.5 Spain Cervical Cancer Diagnostic Market
        • 6.2.3.5.1 Spain Cervical Cancer Diagnostic Market by Type
        • 6.2.3.5.2 Spain Cervical Cancer Diagnostic Market by Age Group
      • 6.2.3.6 Italy Cervical Cancer Diagnostic Market
        • 6.2.3.6.1 Italy Cervical Cancer Diagnostic Market by Type
        • 6.2.3.6.2 Italy Cervical Cancer Diagnostic Market by Age Group
      • 6.2.3.7 Rest of Europe Cervical Cancer Diagnostic Market
        • 6.2.3.7.1 Rest of Europe Cervical Cancer Diagnostic Market by Type
        • 6.2.3.7.2 Rest of Europe Cervical Cancer Diagnostic Market by Age Group
  • 6.3 Asia Pacific Cervical Cancer Diagnostic Market
    • 6.3.1 Asia Pacific Cervical Cancer Diagnostic Market by Type
      • 6.3.1.1 Asia Pacific Pap Smear Tests Market by Country
      • 6.3.1.2 Asia Pacific Colposcopy Tests Market by Country
      • 6.3.1.3 Asia Pacific HPV Test Market by Country
      • 6.3.1.4 Asia Pacific Biopsy & ECC Market by Country
      • 6.3.1.5 Asia Pacific Others Market by Country
    • 6.3.2 Asia Pacific Cervical Cancer Diagnostic Market by Age Group
      • 6.3.2.1 Asia Pacific 20 to 40 years Market by Country
      • 6.3.2.2 Asia Pacific Above 40 years Market by Country
    • 6.3.3 Asia Pacific Cervical Cancer Diagnostic Market by Country
      • 6.3.3.1 China Cervical Cancer Diagnostic Market
        • 6.3.3.1.1 China Cervical Cancer Diagnostic Market by Type
        • 6.3.3.1.2 China Cervical Cancer Diagnostic Market by Age Group
      • 6.3.3.2 Japan Cervical Cancer Diagnostic Market
        • 6.3.3.2.1 Japan Cervical Cancer Diagnostic Market by Type
        • 6.3.3.2.2 Japan Cervical Cancer Diagnostic Market by Age Group
      • 6.3.3.3 India Cervical Cancer Diagnostic Market
        • 6.3.3.3.1 India Cervical Cancer Diagnostic Market by Type
        • 6.3.3.3.2 India Cervical Cancer Diagnostic Market by Age Group
      • 6.3.3.4 South Korea Cervical Cancer Diagnostic Market
        • 6.3.3.4.1 South Korea Cervical Cancer Diagnostic Market by Type
        • 6.3.3.4.2 South Korea Cervical Cancer Diagnostic Market by Age Group
      • 6.3.3.5 Singapore Cervical Cancer Diagnostic Market
        • 6.3.3.5.1 Singapore Cervical Cancer Diagnostic Market by Type
        • 6.3.3.5.2 Singapore Cervical Cancer Diagnostic Market by Age Group
      • 6.3.3.6 Malaysia Cervical Cancer Diagnostic Market
        • 6.3.3.6.1 Malaysia Cervical Cancer Diagnostic Market by Type
        • 6.3.3.6.2 Malaysia Cervical Cancer Diagnostic Market by Age Group
      • 6.3.3.7 Rest of Asia Pacific Cervical Cancer Diagnostic Market
        • 6.3.3.7.1 Rest of Asia Pacific Cervical Cancer Diagnostic Market by Type
        • 6.3.3.7.2 Rest of Asia Pacific Cervical Cancer Diagnostic Market by Age Group
  • 6.4 LAMEA Cervical Cancer Diagnostic Market
    • 6.4.1 LAMEA Cervical Cancer Diagnostic Market by Type
      • 6.4.1.1 LAMEA Pap Smear Tests Market by Country
      • 6.4.1.2 LAMEA Colposcopy Tests Market by Country
      • 6.4.1.3 LAMEA HPV Test Market by Country
      • 6.4.1.4 LAMEA Biopsy & ECC Market by Country
      • 6.4.1.5 LAMEA Others Market by Country
    • 6.4.2 LAMEA Cervical Cancer Diagnostic Market by Age Group
      • 6.4.2.1 LAMEA 20 to 40 years Market by Country
      • 6.4.2.2 LAMEA Above 40 years Market by Country
    • 6.4.3 LAMEA Cervical Cancer Diagnostic Market by Country
      • 6.4.3.1 Brazil Cervical Cancer Diagnostic Market
        • 6.4.3.1.1 Brazil Cervical Cancer Diagnostic Market by Type
        • 6.4.3.1.2 Brazil Cervical Cancer Diagnostic Market by Age Group
      • 6.4.3.2 Argentina Cervical Cancer Diagnostic Market
        • 6.4.3.2.1 Argentina Cervical Cancer Diagnostic Market by Type
        • 6.4.3.2.2 Argentina Cervical Cancer Diagnostic Market by Age Group
      • 6.4.3.3 UAE Cervical Cancer Diagnostic Market
        • 6.4.3.3.1 UAE Cervical Cancer Diagnostic Market by Type
        • 6.4.3.3.2 UAE Cervical Cancer Diagnostic Market by Age Group
      • 6.4.3.4 Saudi Arabia Cervical Cancer Diagnostic Market
        • 6.4.3.4.1 Saudi Arabia Cervical Cancer Diagnostic Market by Type
        • 6.4.3.4.2 Saudi Arabia Cervical Cancer Diagnostic Market by Age Group
      • 6.4.3.5 South Africa Cervical Cancer Diagnostic Market
        • 6.4.3.5.1 South Africa Cervical Cancer Diagnostic Market by Type
        • 6.4.3.5.2 South Africa Cervical Cancer Diagnostic Market by Age Group
      • 6.4.3.6 Nigeria Cervical Cancer Diagnostic Market
        • 6.4.3.6.1 Nigeria Cervical Cancer Diagnostic Market by Type
        • 6.4.3.6.2 Nigeria Cervical Cancer Diagnostic Market by Age Group
      • 6.4.3.7 Rest of LAMEA Cervical Cancer Diagnostic Market
        • 6.4.3.7.1 Rest of LAMEA Cervical Cancer Diagnostic Market by Type
        • 6.4.3.7.2 Rest of LAMEA Cervical Cancer Diagnostic Market by Age Group

Chapter 7. Company Profiles

  • 7.1 Abbott Laboratories
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expense
    • 7.1.5 SWOT Analysis
  • 7.2 Becton, Dickinson and Company
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Segmental and Regional Analysis
    • 7.2.4 Research & Development Expense
    • 7.2.5 Recent strategies and developments:
      • 7.2.5.1 Partnerships, Collaborations, and Agreements:
      • 7.2.5.2 Product Launches and Product Expansions:
      • 7.2.5.3 Acquisition and Mergers:
    • 7.2.6 SWOT Analysis
  • 7.3 Carl Zeiss AG
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental and Regional Analysis
    • 7.3.4 Research & Development Expenses
  • 7.4 CooperSurgical, Inc. (The Cooper Companies, Inc.)
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expense
  • 7.5 DYSIS Medical, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Recent strategies and developments:
      • 7.5.2.1 Product Launches and Product Expansions:
  • 7.6 F. Hoffmann-La Roche Ltd.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expense
    • 7.6.5 Recent strategies and developments:
      • 7.6.5.1 Partnerships, Collaborations, and Agreements:
      • 7.6.5.2 Product Launches and Product Expansions:
      • 7.6.5.3 Acquisition and Mergers:
  • 7.7 Hologic, Inc.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental and Regional Analysis
    • 7.7.4 Research & Development Expenses
    • 7.7.5 Recent strategies and developments:
      • 7.7.5.1 Partnerships, Collaborations, and Agreements:
      • 7.7.5.2 Product Launches and Product Expansions:
      • 7.7.5.3 Geographical Expansions:
  • 7.8 Qiagen N.V.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Regional Analysis
    • 7.8.4 Research & Development Expense
    • 7.8.5 Recent strategies and developments:
      • 7.8.5.1 Partnerships, Collaborations, and Agreements:
      • 7.8.5.2 Product Launches and Product Expansions:
      • 7.8.5.3 Acquisition and Mergers:
  • 7.9 Siemens Healthineers AG (Siemens AG)
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental and Regional Analysis
    • 7.9.4 Research & Development Expense
    • 7.9.5 SWOT Analysis
  • 7.10. Thermo Fisher Scientific, Inc.
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Segmental and Regional Analysis
    • 7.10.4 Research & Development Expenses
    • 7.10.5 SWOT Analysis